{"nct_id":"NCT03628053","title":"Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia","status":"WITHDRAWN","status_verified_date":"2020-07","start_date":"2020-06-05","start_date_type":"ESTIMATED","primary_completion_date":"2025-10-08","primary_completion_date_type":"ESTIMATED","completion_date":"2026-01-07","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}